You just read:

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

News provided by

Frost & Sullivan

01 Feb, 2018, 16:43 GMT